These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10494175)

  • 21. [High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group].
    Nakagawa S; Miki T; Akaza H; Ozono S; Okano T; Sonoda Y; Tsukamoto T; Terachi T; Naito K; Naito S; Nishiyama T; Nonomura N; Hara I; Hoshi S; Yoshida O
    Hinyokika Kiyo; 1999 Nov; 45(11):805-9. PubMed ID: 10637748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
    Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial.
    Thomas X; Elhamri M; Chelghoum Y; Reman O; Arnaud P; Raffoux E; Le QH; Tavernier E; Dombret H; Michallet M
    Ann Hematol; 2005 Jun; 84(6):376-82. PubMed ID: 15782343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematological toxicity of salvage treatment after high-dose chemotherapy and conventional chemotherapy of ovarian cancer.
    Vuento MH; Salmi TA; Remes KJ; Grénman SE
    Anticancer Res; 2002; 22(2B):1151-5. PubMed ID: 12168916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer.
    Cook S; Penson R; Duska L; Nikrui N; Goodman A; Fuller A; Seiden M
    Gynecol Oncol; 2000 Apr; 77(1):48-54. PubMed ID: 10739690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation.
    Lee CK; de Magalhaes-Silverman M; Hayashi M; Schlueter A; Strauss RG; Hohl RJ; Gingrich RD
    Bone Marrow Transplant; 2002 Apr; 29(8):647-52. PubMed ID: 12180108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer.
    Schneeweiss A; Hensel M; Goerner R; Khbeis T; Hohaus S; Egerer G; Solomayer E; Haas R; Grischke EM; Bastert G; Ho AD
    Stem Cells; 2001; 19(2):151-60. PubMed ID: 11239170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of autologous hematopoietic cell transplantation in adult acute myelogenous leukemia].
    Rucińska M; Machaczka M; Piatkowska-Jakubas B; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():44-51. PubMed ID: 10494182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose chemotherapy as salvage treatment for seminoma.
    Rick O; Siegert W; Schwella N; Dubiel M; Krusch A; Beyer J
    Bone Marrow Transplant; 2002 Aug; 30(3):157-60. PubMed ID: 12189533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. II. The experience of the Hematological Intensive Care Unit of the IPOFG. Franciso Gentil Portuguese Institute of Oncology].
    Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
    Acta Med Port; 1999; 12(7-11):275-81. PubMed ID: 10707465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
    Harada M
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.
    Shimoni A; Smith TL; Aleman A; Weber D; Dimopoulos M; Anderlini P; Andersson B; Claxton D; Ueno NT; Khouri I; Donato M; Korbling M; Alexanian R; Champlin R; Giralt S
    Bone Marrow Transplant; 2001 Apr; 27(8):821-8. PubMed ID: 11477439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies.
    Demirer T; Ilhan O; Mandel NM; Arat M; Günel N; Celebi H; Ustün C; Akan H; Demirer S; Aydintuğ S; Uysal A; Koç H
    Bone Marrow Transplant; 2000 Apr; 25(7):697-703. PubMed ID: 10745253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
    Motomura S; Hashimoto C; Kodama F; Maruta A; Sakai R; Fujita H; Tomita N; Fujisawa S; Harano H; Koharazawa H; Fujimaki K; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 May; 46(5):350-7. PubMed ID: 16444968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. I. The rationale and results].
    Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
    Acta Med Port; 1999; 12(7-11):265-73. PubMed ID: 10707464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [High-dose chemotherapy--a new hope for some patients with malignant tumors?].
    Mayer J
    Vnitr Lek; 1997 Dec; 43(12):809-14. PubMed ID: 9601895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
    Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.